A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia
Clinical trial NCT07168694 · COMPLETED
Trial details
- NCT number
- NCT07168694
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-16
- Primary completion
- 2024-09-26
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.